Texas Permanent School Fund Organogenesis Holdings Inc. Transaction History

Texas Permanent School Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.48 - $3.43 $8,298 - $11,476	-3,346 Reduced 6.67%	46,845 $126,000
Q3 2022 Oct 25, 2022	BUY	$3.14 - $6.43 $15,492 - $31,725	4,934 Added 10.9%	50,191 $163,000
Q2 2022 Aug 08, 2022	BUY	$4.74 - $8.15 $2,692 - $4,629	568 Added 1.27%	45,257 $221,000
Q1 2022 May 06, 2022	SELL	$6.47 - $9.57 $4,897 - $7,244	-757 Reduced 1.67%	44,689 $341,000
Q4 2021 Feb 08, 2022	SELL	$9.02 - $13.5 $10,481 - $15,687	-1,162 Reduced 2.49%	45,446 $420,000
Q3 2021 Oct 28, 2021	BUY	$13.71 - $17.18 $128,092 - $160,512	9,343 Added 25.07%	46,608 $664,000
Q2 2021 Jul 27, 2021	BUY	$14.92 - $23.23 $555,993 - $865,665	37,265 New	37,265 $619,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

Stay updated on Texas Permanent School Fund with notifications on news.